FDA 483 - Maria Alora Palli, M.D. - April 29, 2019

An FDA inspection of Massachusetts General Hospital Clinical Unit for Research Trials in Skin (CURTIS) in Boston, MA, revealed a significant issue regarding adherence to investigational plans. The firm failed to conduct an investigation in accordance with its protocol, specifically concerning the administration of instructions to study subjects. This indicates a deviation from established clinical trial procedures.